• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于血管内放射治疗的188Re标记放射性药物的自动化制备

Automated preparation of 188Re-labeled radiopharmaceuticals for endovascular radiation therapy.

作者信息

Oh Seung Jun, Moon Dae Hyuk, Lee Won Woo, Park Seong-Wook, Hong Myeong-Ki, Park Seung-Jung, Shin Dong-Ik, Lee Hee Kyung

机构信息

Departments of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-2dong, Songpa-gu, Seoul 138-736, South Korea.

出版信息

Appl Radiat Isot. 2003 Oct;59(4):225-30. doi: 10.1016/s0969-8043(03)00170-2.

DOI:10.1016/s0969-8043(03)00170-2
PMID:14522229
Abstract

We have developed an automated system for the preparation of highly concentrated 188Re-perrhenate, diethylenetriamine pentaacetic acid (DTPA) and mercaptoacetyltriglycine (MAG3). The three procedural steps include concentration of 188Re-perrhanerate, chelation and purification and sterilization. The steps are operated by a small micro-controller. The eluted 188Re-perrhenate of 15 GBq/18 ml from 37 GBq 188W/188Re-generator was concentrated to 1.2 ml in 10 +/- 0.5 min with a recovery yield of 95 +/- 1.5%. We obtained the highest radiochemical yield of 95.4 +/- 2.8% and 98.5 +/- 1.2% for 188Re-DTPA and MAG3 at the oil bath temperatures of 95-97 degrees C and 93-97 degrees C, respectively.

摘要

我们已经开发出一种自动化系统,用于制备高浓度的188铼过铼酸盐、二乙烯三胺五乙酸(DTPA)和巯基乙酰三甘氨酸(MAG3)。这三个程序步骤包括188铼过铼酸盐的浓缩、螯合以及纯化和灭菌。这些步骤由一个小型微控制器操作。从37GBq的188钨/188铼发生器中洗脱出来的15GBq/18ml的188铼过铼酸盐在10±0.5分钟内浓缩至1.2ml,回收率为95±1.5%。在油浴温度分别为95 - 97摄氏度和93 - 97摄氏度时,我们获得的188铼 - DTPA和MAG3的最高放射化学产率分别为95.4±2.8%和98.5±1.2%。

相似文献

1
Automated preparation of 188Re-labeled radiopharmaceuticals for endovascular radiation therapy.用于血管内放射治疗的188Re标记放射性药物的自动化制备
Appl Radiat Isot. 2003 Oct;59(4):225-30. doi: 10.1016/s0969-8043(03)00170-2.
2
A semi-automated system for concentration of rhenium-188 for radiopharmaceutical applications.一种用于放射性药物应用中铼-188浓缩的半自动系统。
Appl Radiat Isot. 2008 Dec;66(12):1876-80. doi: 10.1016/j.apradiso.2008.04.015. Epub 2008 May 3.
3
A design for automatic preparation of highly concentrated 188Re-perrhenate solutions.
Appl Radiat Isot. 2007 Jan;65(1):21-5. doi: 10.1016/j.apradiso.2006.03.016. Epub 2006 May 24.
4
Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.使用溶液放射性同位素进行血管内β射线照射预防再狭窄:铼-188化合物的药理学和剂量学特性
Cardiovasc Radiat Med. 1999 Jan-Mar;1(1):86-97. doi: 10.1016/s1522-1865(98)00009-2.
5
Holmium-166-DTPA as a liquid source for endovascular brachytherapy.钬-166-二乙三胺五乙酸作为血管内近距离治疗的液体源。
Nucl Med Biol. 2002 Nov;29(8):833-9. doi: 10.1016/s0969-8051(02)00329-3.
6
Concentration protocol of rhenium-188 perrhenate eluted from tungsten-188/rhenium-188 generator for the preparation of high-yield rhenium-188-labelled radiopharmaceuticals.从钨-188/铼-188发生器洗脱的高锝[99mTc]酸钠制备高产量铼-188标记放射性药物的浓缩方案。 (注:原文中“rhenium-188 perrhenate”可能有误,推测应为“technetium-99m pertechnetate”,以上译文是基于纠正后的推测进行翻译,若原文无误,请提供更多背景信息以便准确翻译。)
Nucl Med Commun. 2018 Oct;39(10):957-959. doi: 10.1097/MNM.0000000000000893.
7
Therapy with 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials.188铼标记放射性药物治疗:初步临床试验的有前景结果综述
Cancer Biother Radiopharm. 2003 Oct;18(5):707-17. doi: 10.1089/108497803770418256.
8
Evaluation of three rhenium-188 candidates for intravascular radiation therapy with liquid-filled balloons to prevent restenosis.评估三种用于血管内放射治疗以预防再狭窄的充液球囊铼-188候选物。
J Nucl Cardiol. 2000 Jan-Feb;7(1):37-42. doi: 10.1067/mnc.2000.102919.
9
Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.用188Re三羰基对吗啉进行放射性标记可提高其体外和体内对再氧化的稳定性。
Nucl Med Commun. 2004 Jul;25(7):731-6. doi: 10.1097/01.mnm.0000130237.91573.34.
10
188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases.188Re标记的双膦酸盐作为骨转移患者治疗的潜在双功能药物。
Appl Radiat Isot. 2005 Apr;62(4):541-9. doi: 10.1016/j.apradiso.2004.10.004.

引用本文的文献

1
Bifunctional chelators for radiorhenium: past, present and future outlook.用于放射性铼的双功能螯合剂:过去、现在与未来展望。
RSC Med Chem. 2022 Jan 14;13(3):217-245. doi: 10.1039/d1md00364j. eCollection 2022 Mar 23.
2
Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.用放射性铼标记生物分子:双功能螯合剂综述
Anticancer Agents Med Chem. 2007 May;7(3):367-77. doi: 10.2174/187152007780618144.
3
Intracoronary brachytherapy for in-stent restenosis: will it remain a viable therapy?
Eur J Nucl Med Mol Imaging. 2004 Sep;31(9):1219-23. doi: 10.1007/s00259-004-1567-0. Epub 2004 Jun 16.